Epam Systems

EPAM · NYSE

$130.68+$3.30 (+2.59%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $127.38

EPAM analyst rating

HoldConsensus of 15 analysts over the last 12 months. 47% rate it a buy.

Strong buy0
Buy7
Hold8
Underperform0
Sell0

12-month price target · 20 analysts

Average $123.85 (−5.2% downside)

Low: $94.94
Now: $130.68
High: $210.00

Upgrades and downgrades

The latest rating actions, newest first

EPAM analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Aug 26, 2026	Downgrade	Overweight → Neutral	$120.00	43%
Guggenheim	Aug 10, 2026	Maintains	Buy	$165.00 → $140.00	26%
TD Cowen	Aug 7, 2026	Maintains	Buy	$131.00 → $120.00	52%
JP Morgan	Aug 7, 2026	Maintains	Overweight	$142.00 → $120.00	43%
Truist Securities	Aug 7, 2026	Maintains	Hold	$112.00 → $110.00	41%
Susquehanna	Aug 7, 2026	Maintains	Positive	$167.00 → $146.00	42%
Needham	Aug 6, 2026	Maintains	Buy	$135.00 → $120.00	45%
William Blair	Aug 6, 2026	Downgrade	Outperform → Market Perform	—	43%
Morgan Stanley	Aug 4, 2026	Maintains	Equal-Weight	$112.00 → $100.00	57%
Citigroup	Jul 27, 2026	Maintains	Neutral	$112.00 → $100.00	64%

The case for and against

Updated Oct 14, 2026

Bull case

EPAM Systems is supported by durable engineering capabilities, a diversified global delivery model, and a leading North American franchise that still represents roughly 60% of revenue, giving it a strong base for long-term demand despite current execution issues. The company’s 2Q26 results beat on revenue and margin, and management raised its CY26 adjusted operating margin outlook to 15.5–16% after delivering 16.4% operating margin, helped by cost discipline, improved pricing, and pyramid optimization. While CY26 revenue growth guidance was cut to +2% to +3% y/y cc amid softer North American buying patterns and AI-related budget shifts, its c.7x revised CY27E EPS valuation leaves risk/reward looking favorable for investors willing to wait for execution to normalize.

Bear case

EPAM Systems is facing a negative outlook because its reported 1Q26 revenue growth of 7.6% was flattered by FX, while organic constant-currency growth of 3.7% lagged the broader market and North America, its largest region at about 57% of revenue, rose only 2.5% as clients delayed discretionary spending. Management cut FY26 revenue guidance on macro deterioration, and the company’s AI-native, vendor-consolidation, and fixed-price initiatives remain uncertain, with roughly 10 large deals and about $600M of AI-native FY26 revenue still requiring execution that is not yet visible in guidance. The thesis is further weakened by structural risks including pricing pressure, AI-driven cannibalization of billable hours, margin drag from a North American go-to-market overhaul, and continued exposure to geopolitics, all of which limit confidence in a durable re-acceleration.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.